Abigail Oriaku
Family · The Woodlands, TXNPI 1265807630
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,373 of the $3,592 with a category attached, or 66.1%. 23 manufacturers reported payments, led by Myovant Sciences Inc. at 34.6% of the total. Reporting peaked in 2022 at $1,481 and has fallen 67.2% since, to $485 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $36.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myovant Sciences Inc.$1K
- Astellas Pharma US Inc$596
- AbbVie$383
- Exeltis, USA Inc.$296
- Evofem Biosciences, Inc.$193
- Mayne Pharma Commercial LLC$138
- plus $742 from 17 others
What the payments were for
- Speaking & faculty fees$1,02028%
- Food & beverage$2,37366%
- Education$1996%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myovant Sciences Inc. | 6 | $1,244 |
| Astellas Pharma US Inc | 18 | $596 |
| AbbVie | 18 | $383 |
| Exeltis, USA Inc. | 11 | $296 |
| Evofem Biosciences, Inc. | 9 | $193 |
| Mayne Pharma Commercial LLC | 2 | $138 |
| Organon | 6 | $130 |
| Sumitomo Pharma America, Inc. | 5 | $126 |
| Bayer | 3 | $80 |
| Exact Sciences | 3 | $64 |
| Mylan Pharmaceuticals Inc. | 3 | $51 |
| Daiichi Sankyo Inc. | 2 | $49 |
| Scynexis, Inc. | 2 | $42 |
| Agile Therapeutics, Inc. | 2 | $32 |
| Biogen | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Boston Scientific | 1 | $22 |
| Smith+Nephew | 1 | $20 |
| Pfizer | 1 | $19 |
| Optumhealth Care Solutions, LLC | 1 | $19 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Davol Inc. | 1 | $13 |
| Mission Pharmacal Company | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$124
- Slynd$122
- Orilissa$116
- ORIAHNN$116
- NEXTSTELLIS$113
How this compares
$3,592 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 12 | $437 |
| Fluconazole | 27 | $132 |
Paid to pharmacies, not to this prescriber.
Other family in The Woodlands
- Maggie LavenderThe Woodlands$76K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.